Literature DB >> 15222691

Serum uric acid levels in optic neuritis.

C M Knapp1, C S Constantinescu, J H Y Tan, R McLean, G R Cherryman, I Gottlob.   

Abstract

Uric acid, an antioxidant, is reduced in multiple sclerosis (MS). Patients with gout have a reduced incidence of MS. Optic neuritis (ON), often the first manifestation of MS, is not known to be associated with reduced uric acid. Patients with recent onset of ON were investigated to determine whether uric acid levels were reduced at presentation. Twenty-one patients with ON were included, 17 females and 4 males. The mean (SD) serum uric acid in the ON female group was 184.4 ( +/-55.1) micromol/L (range, 116-309 micromol/L), whilst in the control group it was 235.2 (+/- 50.2) micromol/L (range, 172-381 micromol/L). The difference was statistically significant (chi2 = 8.93, P = 0.003). In the small male cohort, mean (SD) serum uric acid was 305 (+/- 52.1) micromol/L, whilst in the control group it was 328 (+/- 80.4) micromol/L. These differences were not statistically significant. Reduced antioxidant reserve is possibly an early pathogenic mechanism in inflammatory demyelination, and raises the possibility that low uric acid levels could be an indicator of disease activity. Since optic neuropathies of other causes were not investigated, future research needs to determine whether low uric acid represents a unique feature of optic neuritis or is seen in other optic neuropathies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222691     DOI: 10.1191/1352458504ms1042oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  12 in total

Review 1.  Administration of Uric Acid in the Emergency Treatment of Acute Ischemic Stroke.

Authors:  Laura Llull; Sergio Amaro; Ángel Chamorro
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

2.  Homeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophrenia.

Authors:  Jeffrey K Yao; George G Dougherty; Ravinder D Reddy; Matcheri S Keshavan; Debra M Montrose; Wayne R Matson; Joseph McEvoy; Rima Kaddurah-Daouk
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

3.  Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.

Authors:  May A Beydoun; Jose-Atilio Canas; Gregory A Dore; Hind A Beydoun; Ola S Rostant; Marie T Fanelli-Kuczmarski; Michele K Evans; Alan B Zonderman
Journal:  J Alzheimers Dis       Date:  2016-04-21       Impact factor: 4.472

Review 4.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

Review 5.  Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis.

Authors:  Sara Cipriani; Xiqun Chen; Michael A Schwarzschild
Journal:  Biomark Med       Date:  2010-10       Impact factor: 2.851

6.  Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.

Authors:  Marcello Moccia; Roberta Lanzillo; Teresa Costabile; Cinzia Russo; Antonio Carotenuto; Gabriella Sasso; Emanuela Postiglione; Carla De Luca Picione; Michele Vastola; Giorgia Teresa Maniscalco; Raffaele Palladino; Vincenzo Brescia Morra
Journal:  J Neurol       Date:  2015-02-12       Impact factor: 4.849

7.  Serum uric acid levels and neuromyelitis optica.

Authors:  Fuhua Peng; Xiufeng Zhong; Xuhui Deng; Wei Qiu; Aimin Wu; Youming Long; Xueqiang Hu; Qing Li; Ying Jiang; Yongqiang Dai
Journal:  J Neurol       Date:  2010-01-22       Impact factor: 4.849

8.  Plasma urate and risk of Parkinson's disease.

Authors:  M G Weisskopf; E O'Reilly; H Chen; M A Schwarzschild; A Ascherio
Journal:  Am J Epidemiol       Date:  2007-06-20       Impact factor: 4.897

9.  Serum uric acid and risk of multiple sclerosis.

Authors:  Jennifer Massa; E O'Reilly; K L Munger; G N Delorenze; A Ascherio
Journal:  J Neurol       Date:  2009-05-26       Impact factor: 4.849

10.  Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis.

Authors:  Jeffrey K Yao; George G Dougherty; Ravinder D Reddy; Wayne R Matson; Rima Kaddurah-Daouk; Matcheri S Keshavan
Journal:  Front Cell Neurosci       Date:  2013-06-11       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.